PDB Short entry for 3P97 HEADER TRANSFERASE/TRANSFERASE INHIBITOR 16-OCT-10 3P97 TITLE DENGUE 3 NS5 METHYLTRANSFERASE BOUND TO THE SUBSTRATE S-ADENOSYL TITLE 2 METHIONINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: NON-STRUCTURAL PROTEIN 5; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: N-TERMINAL DOMAIN; COMPND 5 EC: 2.1.1.56, 2.1.1.57; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: DENGUE VIRUS 3; SOURCE 3 ORGANISM_TAXID: 11069; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PGEX KEYWDS 2'O METHYLTRANSFERASE, N7 METHYLTRANSFERASE, NS3, TRANSFERASE- KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.G.NOBLE,L.J.YAP,J.LESCAR REVDAT 3 01-NOV-23 3P97 1 REMARK SEQADV REVDAT 2 28-SEP-11 3P97 1 JRNL VERSN REVDAT 1 08-DEC-10 3P97 0 JRNL AUTH S.P.LIM,L.S.SONNTAG,C.NOBLE,S.H.NILAR,R.H.NG,G.ZOU, JRNL AUTH 2 P.MONAGHAN,K.Y.CHUNG,H.DONG,B.LIU,C.BODENREIDER,G.LEE, JRNL AUTH 3 M.DING,W.L.CHAN,G.WANG,Y.L.JIAN,A.T.CHAO,J.LESCAR,Z.YIN, JRNL AUTH 4 T.R.VEDANANDA,T.H.KELLER,P.Y.SHI JRNL TITL SMALL MOLECULE INHIBITORS THAT SELECTIVELY BLOCK DENGUE JRNL TITL 2 VIRUS METHYLTRANSFERASE JRNL REF J.BIOL.CHEM. V. 286 6233 2011 JRNL REFN ISSN 0021-9258 JRNL PMID 21147775 JRNL DOI 10.1074/JBC.M110.179184 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 62652 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3345 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.74 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4585 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2800 REMARK 3 BIN FREE R VALUE SET COUNT : 225 REMARK 3 BIN FREE R VALUE : 0.3190 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4086 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 689 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.32 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.02000 REMARK 3 B22 (A**2) : -0.72000 REMARK 3 B33 (A**2) : 0.70000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.106 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.072 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.152 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.941 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4263 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5758 ; 1.643 ; 1.982 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 518 ;18.337 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 183 ;30.212 ;22.787 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 795 ;14.057 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 40 ;15.197 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 622 ; 0.130 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3164 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2111 ; 0.201 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2876 ; 0.302 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 510 ; 0.157 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 54 ; 0.189 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 32 ; 0.139 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2637 ; 0.997 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4154 ; 1.434 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1880 ; 2.307 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1600 ; 3.577 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3P97 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 02-NOV-10. REMARK 100 THE DEPOSITION ID IS D_1000062114. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUN-10 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 62652 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 51.850 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1L9K REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 22.5% PEG8000, 200MM NACL, 20MM REMARK 280 NA3CITRATE, 100MM TRIS-HCL, PH 8.5, VAPOR DIFFUSION, TEMPERATURE REMARK 280 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.54850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 93.01750 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 30.54850 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 93.01750 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH C 683 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -4 REMARK 465 PRO A -3 REMARK 465 LEU A -2 REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 GLY A 1 REMARK 465 THR A 2 REMARK 465 GLY A 3 REMARK 465 SER A 4 REMARK 465 GLN A 5 REMARK 465 GLY A 6 REMARK 465 GLY C -4 REMARK 465 PRO C -3 REMARK 465 LEU C -2 REMARK 465 GLY C -1 REMARK 465 SER C 0 REMARK 465 GLY C 1 REMARK 465 THR C 2 REMARK 465 GLY C 3 REMARK 465 SER C 4 REMARK 465 GLN C 5 REMARK 465 GLY C 6 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 82 N - CA - C ANGL. DEV. = 16.3 DEGREES REMARK 500 ALA A 259 N - CA - C ANGL. DEV. = 19.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 15 -78.39 6.89 REMARK 500 HIS A 52 -50.27 69.24 REMARK 500 CYS A 82 -35.36 -38.24 REMARK 500 HIS A 110 118.00 -164.00 REMARK 500 HIS C 52 -50.70 71.84 REMARK 500 ARG C 247 78.40 46.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LYS A 14 LYS A 15 121.95 REMARK 500 PRO A 108 GLY A 109 -130.21 REMARK 500 GLY A 109 HIS A 110 -86.39 REMARK 500 ASP A 256 LEU A 257 -138.99 REMARK 500 GLY A 258 ALA A 259 95.87 REMARK 500 PRO C 108 GLY C 109 -38.86 REMARK 500 MET C 244 THR C 245 59.10 REMARK 500 ASP C 256 LEU C 257 -148.16 REMARK 500 GLY C 258 ALA C 259 -131.26 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAM A 263 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAM C 263 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3P8Z RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH AN INHIBITOR AND FROM THE SAME REMARK 900 PUBLICATION DBREF 3P97 A 1 262 UNP C1KBQ3 C1KBQ3_9FLAV 2491 2752 DBREF 3P97 C 1 262 UNP C1KBQ3 C1KBQ3_9FLAV 2491 2752 SEQADV 3P97 GLY A -4 UNP C1KBQ3 EXPRESSION TAG SEQADV 3P97 PRO A -3 UNP C1KBQ3 EXPRESSION TAG SEQADV 3P97 LEU A -2 UNP C1KBQ3 EXPRESSION TAG SEQADV 3P97 GLY A -1 UNP C1KBQ3 EXPRESSION TAG SEQADV 3P97 SER A 0 UNP C1KBQ3 EXPRESSION TAG SEQADV 3P97 GLY C -4 UNP C1KBQ3 EXPRESSION TAG SEQADV 3P97 PRO C -3 UNP C1KBQ3 EXPRESSION TAG SEQADV 3P97 LEU C -2 UNP C1KBQ3 EXPRESSION TAG SEQADV 3P97 GLY C -1 UNP C1KBQ3 EXPRESSION TAG SEQADV 3P97 SER C 0 UNP C1KBQ3 EXPRESSION TAG SEQRES 1 A 267 GLY PRO LEU GLY SER GLY THR GLY SER GLN GLY GLU THR SEQRES 2 A 267 LEU GLY GLU LYS TRP LYS LYS LYS LEU ASN GLN LEU SER SEQRES 3 A 267 ARG LYS GLU PHE ASP LEU TYR LYS LYS SER GLY ILE THR SEQRES 4 A 267 GLU VAL ASP ARG THR GLU ALA LYS GLU GLY LEU LYS ARG SEQRES 5 A 267 GLY GLU THR THR HIS HIS ALA VAL SER ARG GLY SER ALA SEQRES 6 A 267 LYS LEU GLN TRP PHE VAL GLU ARG ASN MET VAL ILE PRO SEQRES 7 A 267 GLU GLY ARG VAL ILE ASP LEU GLY CYS GLY ARG GLY GLY SEQRES 8 A 267 TRP SER TYR TYR CYS ALA GLY LEU LYS LYS VAL THR GLU SEQRES 9 A 267 VAL ARG GLY TYR THR LYS GLY GLY PRO GLY HIS GLU GLU SEQRES 10 A 267 PRO VAL PRO MET SER THR TYR GLY TRP ASN ILE VAL LYS SEQRES 11 A 267 LEU MET SER GLY LYS ASP VAL PHE TYR LEU PRO PRO GLU SEQRES 12 A 267 LYS CYS ASP THR LEU LEU CYS ASP ILE GLY GLU SER SER SEQRES 13 A 267 PRO SER PRO THR VAL GLU GLU SER ARG THR ILE ARG VAL SEQRES 14 A 267 LEU LYS MET VAL GLU PRO TRP LEU LYS ASN ASN GLN PHE SEQRES 15 A 267 CYS ILE LYS VAL LEU ASN PRO TYR MET PRO THR VAL ILE SEQRES 16 A 267 GLU HIS LEU GLU ARG LEU GLN ARG LYS HIS GLY GLY MET SEQRES 17 A 267 LEU VAL ARG ASN PRO LEU SER ARG ASN SER THR HIS GLU SEQRES 18 A 267 MET TYR TRP ILE SER ASN GLY THR GLY ASN ILE VAL SER SEQRES 19 A 267 SER VAL ASN MET VAL SER ARG LEU LEU LEU ASN ARG PHE SEQRES 20 A 267 THR MET THR HIS ARG ARG PRO THR ILE GLU LYS ASP VAL SEQRES 21 A 267 ASP LEU GLY ALA GLY THR ARG SEQRES 1 C 267 GLY PRO LEU GLY SER GLY THR GLY SER GLN GLY GLU THR SEQRES 2 C 267 LEU GLY GLU LYS TRP LYS LYS LYS LEU ASN GLN LEU SER SEQRES 3 C 267 ARG LYS GLU PHE ASP LEU TYR LYS LYS SER GLY ILE THR SEQRES 4 C 267 GLU VAL ASP ARG THR GLU ALA LYS GLU GLY LEU LYS ARG SEQRES 5 C 267 GLY GLU THR THR HIS HIS ALA VAL SER ARG GLY SER ALA SEQRES 6 C 267 LYS LEU GLN TRP PHE VAL GLU ARG ASN MET VAL ILE PRO SEQRES 7 C 267 GLU GLY ARG VAL ILE ASP LEU GLY CYS GLY ARG GLY GLY SEQRES 8 C 267 TRP SER TYR TYR CYS ALA GLY LEU LYS LYS VAL THR GLU SEQRES 9 C 267 VAL ARG GLY TYR THR LYS GLY GLY PRO GLY HIS GLU GLU SEQRES 10 C 267 PRO VAL PRO MET SER THR TYR GLY TRP ASN ILE VAL LYS SEQRES 11 C 267 LEU MET SER GLY LYS ASP VAL PHE TYR LEU PRO PRO GLU SEQRES 12 C 267 LYS CYS ASP THR LEU LEU CYS ASP ILE GLY GLU SER SER SEQRES 13 C 267 PRO SER PRO THR VAL GLU GLU SER ARG THR ILE ARG VAL SEQRES 14 C 267 LEU LYS MET VAL GLU PRO TRP LEU LYS ASN ASN GLN PHE SEQRES 15 C 267 CYS ILE LYS VAL LEU ASN PRO TYR MET PRO THR VAL ILE SEQRES 16 C 267 GLU HIS LEU GLU ARG LEU GLN ARG LYS HIS GLY GLY MET SEQRES 17 C 267 LEU VAL ARG ASN PRO LEU SER ARG ASN SER THR HIS GLU SEQRES 18 C 267 MET TYR TRP ILE SER ASN GLY THR GLY ASN ILE VAL SER SEQRES 19 C 267 SER VAL ASN MET VAL SER ARG LEU LEU LEU ASN ARG PHE SEQRES 20 C 267 THR MET THR HIS ARG ARG PRO THR ILE GLU LYS ASP VAL SEQRES 21 C 267 ASP LEU GLY ALA GLY THR ARG HET SAM A 263 27 HET SAM C 263 27 HETNAM SAM S-ADENOSYLMETHIONINE FORMUL 3 SAM 2(C15 H22 N6 O5 S) FORMUL 5 HOH *689(H2 O) HELIX 1 1 THR A 8 LEU A 20 1 13 HELIX 2 2 SER A 21 LYS A 29 1 9 HELIX 3 3 ARG A 38 ARG A 47 1 10 HELIX 4 4 ARG A 57 ARG A 68 1 12 HELIX 5 5 GLY A 85 GLY A 93 1 9 HELIX 6 6 GLY A 120 ASN A 122 5 3 HELIX 7 7 ASP A 131 LEU A 135 5 5 HELIX 8 8 SER A 153 GLU A 169 1 17 HELIX 9 9 PRO A 170 LEU A 172 5 3 HELIX 10 10 MET A 186 GLY A 201 1 16 HELIX 11 11 ASN A 226 ARG A 241 1 16 HELIX 12 12 THR C 8 GLN C 19 1 12 HELIX 13 13 SER C 21 LYS C 29 1 9 HELIX 14 14 ARG C 38 ARG C 47 1 10 HELIX 15 15 ARG C 57 GLU C 67 1 11 HELIX 16 16 GLY C 85 ALA C 92 1 8 HELIX 17 17 GLY C 120 ASN C 122 5 3 HELIX 18 18 ASP C 131 LEU C 135 5 5 HELIX 19 19 SER C 153 GLU C 169 1 17 HELIX 20 20 PRO C 170 LEU C 172 5 3 HELIX 21 21 MET C 186 GLY C 201 1 16 HELIX 22 22 ASN C 226 MET C 244 1 19 SHEET 1 A 2 THR A 34 ASP A 37 0 SHEET 2 A 2 THR A 250 LYS A 253 1 O GLU A 252 N ASP A 37 SHEET 1 B 7 VAL A 124 MET A 127 0 SHEET 2 B 7 VAL A 97 TYR A 103 1 N GLY A 102 O MET A 127 SHEET 3 B 7 GLY A 75 LEU A 80 1 N VAL A 77 O GLU A 99 SHEET 4 B 7 THR A 142 CYS A 145 1 O LEU A 144 N ILE A 78 SHEET 5 B 7 GLN A 176 VAL A 181 1 O LYS A 180 N CYS A 145 SHEET 6 B 7 MET A 217 ILE A 220 -1 O MET A 217 N VAL A 181 SHEET 7 B 7 MET A 203 VAL A 205 -1 N VAL A 205 O TYR A 218 SHEET 1 C 2 THR C 34 ASP C 37 0 SHEET 2 C 2 THR C 250 LYS C 253 1 O THR C 250 N GLU C 35 SHEET 1 D 7 VAL C 124 MET C 127 0 SHEET 2 D 7 VAL C 97 TYR C 103 1 N GLY C 102 O MET C 127 SHEET 3 D 7 GLY C 75 LEU C 80 1 N VAL C 77 O GLU C 99 SHEET 4 D 7 THR C 142 CYS C 145 1 O LEU C 144 N ILE C 78 SHEET 5 D 7 GLN C 176 VAL C 181 1 O GLN C 176 N LEU C 143 SHEET 6 D 7 MET C 217 ILE C 220 -1 O MET C 217 N VAL C 181 SHEET 7 D 7 MET C 203 VAL C 205 -1 N MET C 203 O ILE C 220 CISPEP 1 HIS C 246 ARG C 247 0 28.68 SITE 1 AC1 20 SER A 56 GLY A 58 GLY A 81 CYS A 82 SITE 2 AC1 20 GLY A 83 GLY A 86 TRP A 87 THR A 104 SITE 3 AC1 20 LYS A 105 HIS A 110 LYS A 130 ASP A 131 SITE 4 AC1 20 VAL A 132 PHE A 133 ASP A 146 HOH A 279 SITE 5 AC1 20 HOH A 283 HOH A 308 HOH A 349 HOH A 359 SITE 1 AC2 22 SER C 56 GLY C 58 GLY C 81 CYS C 82 SITE 2 AC2 22 GLY C 83 GLY C 86 TRP C 87 THR C 104 SITE 3 AC2 22 LYS C 105 HIS C 110 GLU C 111 LYS C 130 SITE 4 AC2 22 ASP C 131 VAL C 132 PHE C 133 ASP C 146 SITE 5 AC2 22 HOH C 270 HOH C 294 HOH C 301 HOH C 343 SITE 6 AC2 22 HOH C 453 HOH C 635 CRYST1 51.818 61.097 186.035 90.00 90.00 90.00 P 2 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019298 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016367 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005375 0.00000